Johannes Oldenburg

58PUBLICATIONS
136CO-AUTHORS
Biomolecular modelling and designHaematologyEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Electrochemical energy storage and conversion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (58)

|Aug 20, 2026
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.

|Jul 21, 2026
In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway.

|Jun 15, 2026
Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

|Aug 12, 2025
Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

Inga M Schimansky, Christiane Dobbelstein, Robert Klamroth

|Jul 23, 2025
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy.

Johannes Oldenburg, Martin Olivieri, Songkai Yan

|Jul 12, 2025
FVIII Trafficking Dynamics Across Subcellular Organelles Using CRISPR/Cas9 Specific Gene Knockouts.

Salime El Hazzouri, Rawya Al-Rifai, Nicole Surges

Pageof 10

Frequent Collaborators

7 joint publications

Behnaz Pezeshkpoor

7 joint publications

Heiko Rühl

7 joint publications

Andreas Christian Strauss

6 joint publications

Johnny N Mahlangu